Recursion Pharmaceuticals Inc (RXRX) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Recursion Pharmaceuticals Inc   (NASDAQ: RXRX)


Recursion Pharmaceuticals Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



RXRX Gross Profit Margin (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Revenue Change -60.1 %
Seq. Revenue Change 18.51 %
Revenue In Millions $7.67
Gross Profit Margin -49.82 %
Gross Profit Margin Total Ranking #
Gross Profit In Millions $-3.82
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Second Quarter 2026 Gross Profit Margin
Recursion Pharmaceuticals Inc Gross Loss of -4 fell compared to Gross Loss of $-6.02 millions a quarter before.


Observing second quarter 2026 results within Biotechnology & Pharmaceuticals industry Recursion Pharmaceuticals Inc has achieved highest Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to , from total ranking in the previous quarter at 1472.
Learn about Gross Margin
RXRX's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall # 0

Gross Profit Margin Statistics
High Average Low
59.83 % 30.52 % 9.28 %
(Dec 31 2025)   (Dec 31 2023)




Other Gross Profit Margin Profitability Ratios
RXRX's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
RXRX's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for RXRX's Competitors
Gross Profit Margin Profit Margin for Recursion Pharmaceuticals Inc 's Suppliers
Gross Profit Margin Profit Margin for RXRX's Customers

You may also want to know
RXRX's Annual Growth Rates RXRX's Profitability Ratios RXRX's Asset Turnover Ratio RXRX's Dividend Growth
RXRX's Roe RXRX's Valuation Ratios RXRX's Financial Strength Ratios RXRX's Gross Profit Growth
RXRX's Roa RXRX's Inventory Turnover Ratio RXRX's Growth Rates RXRX's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.